grober
MB Master
Maybe this ?
Medical cannabis - Wikipedia, the free encyclopedia
And this
Cannabis and Cannabinoids (PDQ®) - National Cancer Institute
While folks tend to focus on the medical efficacy of new anti cancer therapies they also highlight the problems society has with effective new drug development. New drugs have an enormous obstacle race of regulatory frameworks to navigate through. Expensive testing regimes involving animals and eventually clinical trials involving human subjects have to be performed before a drug can be brought to market. While designed to prevent unsafe drugs reaching the general populace and admirable in conception this costs enormous sums of money. Cannabinoids are naturally occurring compounds so I imagine they can't be effectively patented. If they can be grown and extracted as a global commodity the chances of controlling their production and supply would be almost impossible. Faced with this dilemma would any large Pharma company with a wary eye on its annual shareholders meeting would be persuaded to fund the appropriate research and development without a guarrantee on returns? One of the complex dilemmas we face in the 21st century and one which has already been felt in the development of new antibiotics.
Here's an example from the "sharp end" of drug development
http://www.bmj.com/content/344/bmj.e3162
Medical cannabis - Wikipedia, the free encyclopedia
And this
Cannabis and Cannabinoids (PDQ®) - National Cancer Institute
While folks tend to focus on the medical efficacy of new anti cancer therapies they also highlight the problems society has with effective new drug development. New drugs have an enormous obstacle race of regulatory frameworks to navigate through. Expensive testing regimes involving animals and eventually clinical trials involving human subjects have to be performed before a drug can be brought to market. While designed to prevent unsafe drugs reaching the general populace and admirable in conception this costs enormous sums of money. Cannabinoids are naturally occurring compounds so I imagine they can't be effectively patented. If they can be grown and extracted as a global commodity the chances of controlling their production and supply would be almost impossible. Faced with this dilemma would any large Pharma company with a wary eye on its annual shareholders meeting would be persuaded to fund the appropriate research and development without a guarrantee on returns? One of the complex dilemmas we face in the 21st century and one which has already been felt in the development of new antibiotics.
Here's an example from the "sharp end" of drug development
http://www.bmj.com/content/344/bmj.e3162
Last edited: